{"id":310602,"date":"2019-12-19T21:58:07","date_gmt":"2019-12-20T05:58:07","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/healthcare-roundup-amgen-files-us-application-for-rituxan-biosimilar-gilead-files-us-application-for-filgotinib\/"},"modified":"2019-12-19T21:58:45","modified_gmt":"2019-12-20T05:58:45","slug":"%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8%e5%ae%89%e9%80%b2%e6%8f%90%e4%ba%a4%e7%be%8e%e5%9c%8b-rituxan-%e7%94%9f%e7%89%a9%e4%bb%bf%e8%a3%bd%e8%97%a5%e7%9a%84%e7%94%b3%e8%ab%8b%e5%90%89","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/12\/%e9%86%ab%e7%99%82%e4%bf%9d%e5%81%a5%e7%b2%be%e9%81%b8%e5%ae%89%e9%80%b2%e6%8f%90%e4%ba%a4%e7%be%8e%e5%9c%8b-rituxan-%e7%94%9f%e7%89%a9%e4%bb%bf%e8%a3%bd%e8%97%a5%e7%9a%84%e7%94%b3%e8%ab%8b%e5%90%89\/","title":{"rendered":"\u91ab\u7642\u4fdd\u5065\u7cbe\u9078\u2014\u2014\u5b89\u9032\u63d0\u4ea4\u7f8e\u570bRituxan\u751f\u7269\u4eff\u88fd\u85e5\u7684\u7533\u8acb\uff0c\u5409\u5229\u5fb7\u63d0\u4ea4\u7f8e\u570bfilgotinib\u7533\u8acb"},"content":{"rendered":"<h2>\u5b89\u9032\u516c\u53f8\u5728\u7f8e\u570b\u63d0\u4ea4Rituxan\u751f\u7269\u4eff\u88fd\u85e5\u7533\u8acb<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=AMGN\">\u5b89\u9032 (NASDAQ:AMGN)<\/a>\u5df2\u5411FDA\u63d0\u4ea4\u4e86\u4e00\u4efd\u71df\u92b7\u7533\u8acb\uff0c\u4ee5\u5c0b\u6c42AMG 798\u7684\u6279\u51c6\uff0c\u8a72\u7522\u54c1\u662f\u7f85\u6c0f\uff08OTCQX\uff1aRHHBY\uff09Rituxan\uff08rituximab\uff09\u7684\u751f\u7269\u4eff\u88fd\u85e5\u3002<\/p>\n<p>\u5b89\u9032\u6b63\u5728\u8207\u827e\u723e\u5065\uff08NYSE\uff1aAGN\uff09\u5408\u4f5c\u958b\u767c\u56db\u7a2e\u751f\u7269\u4eff\u88fd\u85e5\uff0c\u5176\u4e2d\u5169\u7a2e\u5728\u7f8e\u570b\u7372\u5f97\u6279\u51c6\u3002\u5b89\u9032\u4e3b\u8981\u8ca0\u8cac\u958b\u767c\u3001\u88fd\u9020\u548c\u521d\u59cb\u5546\u696d\u5316\u3002<\/p>\n<h2>\u5409\u5229\u5fb7\u63d0\u4ea4filgotinib\u6cbb\u7642\u985e\u98a8\u6fd5\u95dc\u7bc0\u708e\u7684\u7533\u8acb<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=GILD\">\u5409\u5229\u5fb7\u79d1\u5b78\u516c\u53f8(NASDAQ:GILD)<\/a>\u5df2\u5411FDA\u63d0\u4ea4\u4e86\u71df\u92b7\u7533\u8acb\uff0c\u4ee5\u5c0b\u6c42\u6279\u51c6filgotinib\u7528\u65bc\u4e2d\u91cd\u5ea6\u985e\u98a8\u6fd5\u95dc\u7bc0\u708e\u60a3\u8005\u3002<\/p>\n<p>\u5409\u5229\u5fb7\u63d0\u4ea4\u4e86\u5e36\u6709\u512a\u5148\u5be9\u67e5\u6191\u8b49\u7684\u7533\u8acb\uff0c\u5982\u679c\u8a72\u6a5f\u69cb\u63a5\u53d7\uff0c\u5247\u53ef\u4ee5\u5c07\u5be9\u67e5\u6642\u9593\u7e2e\u77ed\u81f3\u516d\u500b\u6708\u3002<\/p>\n<p>\u6839\u64da2015\u5e74\u7684\u5354\u8b70\uff0c\u5409\u5229\u5fb7\u5c07\u8207<a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=GLPG\">Galapagos NV\uff08NASDAQ\uff1aGLPG\uff09<\/a>\u5171\u540c\u958b\u767cJAK1\u6291\u5236\u5291\u4e26\u5c07\u5176\u5546\u696d\u5316\u3002\u8a72\u6587\u4ef6\u89f8\u767c\u4e86\u5409\u5229\u5fb7\u5411GLPG\u652f\u4ed82,000\u842c\u7f8e\u5143\u7684\u91cc\u7a0b\u7891\u4ed8\u6b3e\u3002<\/p>\n<h2>Biogen\u56de\u8cfc\u80a1\u7968<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=BIIB\">Biogen\uff08NASDAQ\uff1aBIIB\uff09<\/a>\u8463\u4e8b\u6703\u5df2\u6388\u6b0a\u56de\u8cfc\u6700\u591a$ 50\u5104\u7684\u6d41\u901a\u5728\u5916\u666e\u901a\u80a1\u3002Biogen\u80a1\u50f9\u6578\u5c0f\u6642\u5f8c\u4e0a\u6f321%\u3002<\/p>\n<h2>\u52a0\u62ff\u5927\u9650\u5236\u96fb\u5b50\u7159\u7522\u54c1\u5ee3\u544a<\/h2>\n<p>\u52a0\u62ff\u5927\u885b\u751f\u90e8\u9577Patty Hajdu\u8868\u793a\uff0c\u5b83\u5c07\u767c\u63ee\u66f4\u5927\u7684\u4f5c\u7528\u4f86\u4fdd\u8b77\u5e74\u8f15\u4eba\uff0c\u4e26\u63d0\u51fa\u4e86\u65b0\u7684\u6cd5\u898f\uff0c\u4ee5\u7981\u6b62\u5728\u5e74\u8f15\u4eba\u53ef\u4ee5\u770b\u5230\u6216\u807d\u5230\u96fb\u5b50\u7159\uff08\u5305\u62ec\u5728\u7dda\uff09\u7684\u4fc3\u92b7\u548c\u5ee3\u544a\u3002<\/p>\n<h2>Hoth Therapeutics\u8207\u5a01\u723e\u5eb7\u5948\u723e\u91ab\u5b78\u9662\u5408\u4f5c<\/h2>\n<p><a href=\"https:\/\/nai500.com\/zh-hant\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%a9%a2\/?qm_symbol=HOTH\">Hoth Therapeutics\uff08NASDAQ\uff1aHOTH\uff09<\/a>\u5df2\u8207\u5a01\u723e\u5eb7\u5948\u723e\u91ab\u5b78\u9662\u9054\u6210\u4e00\u9805\u7814\u7a76\u5408\u4f5c\u5354\u8b70\uff0c\u4ee5\u6aa2\u67e5\u8996\u9ec3\u9178\u4ee3\u8b1d\u963b\u65b7\u5291\uff08RAMBA\uff09\u963b\u65b7\u4eba\u89d2\u8cea\u5f62\u6210\u7d30\u80de\uff0c\u5c0f\u9f20\u76ae\u819a\u4e2d\u75e4\u7621\u81f4\u75c5\u57fa\u56e0\u8868\u9054\u4ee5\u53ca\u5c0f\u9f20\u81f4\u764c\u4f5c\u7528\u7684\u80fd\u529b\u3002<\/p>\n<p>\u7814\u7a76\u5408\u4f5c\u5c07\u5206\u4e09\u500b\u968e\u6bb5\u9032\u884c\uff0c\u70ba\u671f\u4e00\u5e74\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amgen (NASDAQ:AMGN) has submitted a marketing application to the FDA seeking approval of AMG 798, a biosimilar to Roche&#8217;s (OTCQX:RHHBY) Rituxan (rituximab). ilead Sciences (NASDAQ:GILD) has submitted a marketing application to the FDA seeking approval of filgotinib for patients with moderate-to-severe rheumatoid arthritis.<\/p>\n","protected":false},"author":9,"featured_media":310594,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,644,564],"class_list":["post-310602","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-644","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/310602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=310602"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/310602\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/310594"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=310602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=310602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=310602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}